| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma | Chua-On, D Proungvitaya, T Techasen, A Limpaiboon, T Roytrakul, S Wongkham, S Wongkham, C Somintara, O Sungkhamanon, S Proungvitaya, S |
2016 | ||||
| 2. | Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells. | Dokduang, H. Yongvanit, P. Namwat, N. Pairojkul, C. Loilome, W. |
2016 | ||||
| 3. | Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment. | Supak Yothaisong Hasaya Dokduang Naohiko Anzai Keitaro Hayashi Nisana Namwat Puangrat Yongvanit Sakkarn Sangkhamanon Promsuk Jutabha Hitoshi Endou Watcharin Loilome |
2017 | ||||
| 4. | MR imaging findings of a patient with isolated intrahepatic splenosis mistaken for hepatocellular carcinoma | Kulyada Somsap Nittaya Chamadol Attapol Titapun Chawalit Pairojkul Sakkarn Sangkhamanon |
2017 | ||||
| 5. | Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process. | Thanee, M. Techasen, A. Namwat, N. Yongvanit, P. Loilome, W. |
2017 | ||||
| 6. | Programmed Death-Ligand 1 (PD-L1) Expression Associated with a High Neutrophil/Lymphocyte Ratio in Cholangiocarcinoma | Sookprasert, A. Wirasorn, K. Titapun, A. Pugkhem, A. |
2017 | ||||
| 7. | Targeting hexokinase II as a possible therapy for cholangiocarcinoma. | Seubwai, W. Phoomak, C. Cha'on, U. Boonmars, T. |
2017 | ||||
| 8. | Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis | Nattaporn Phanthaphol Anchalee Techasen Watcharin Loilome Suyanee Thongchot Raynoo Thanan Sakkarn Sungkhamanon Narong Khuntikeo Puangrat Yongvanit Nisana Namwat |
2017 | ||||
| 9. | Biopsy Global Grade Group vs. Highest Grade Group vs. Largest Volume Cancer Grade Group: Concordance of Biopsy 'Case Level' and Radical Prostatectomy Grade Groups | Kiril Trpkov Sakkarn Sangkhamanon Asli Yilmaz Shaun Medlicott Panche Zdravkovski Tarek Bismar Melissa A. Shea-Budgell |
2018 | ||||
| 10. | Bladder Malakoplakia in Systemic Sclerosis Patient: A Case Report and Review Literature. | Sirithanaphol, W Sangkhamanon, S Netwijitpan, S Foocharoen, C |
2018 | ||||
| 11. | Concordance of Case Level Global, Highest, and Largest Volume Cancer Grade Group on Needle Biopsy Versus Grade Group on Radical Prostatectomy | Trpkov, K Sangkhamanon, S Yilmaz, A Medlicott, SAC Donnelly, B Gotto, G Shea-Budgell, M |
2018 | ||||
| 12. | Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth. | Dokduang, H. Yothaisong, S. Techasen, A. Yongvanit, P. Khuntikeo, N. Titapun, A. Loilome, |
2018 | ||||
| 13. | Pan-class I PI3K inhibitor inhibits cholangiocarcinoma cell growth | Sureerat Padthaisong Hasaya Dokduang Supak Yothaisong Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapon Titapun Sakkarn Sangkhamanon Watcharin Loilome |
2018 | ||||
| 14. | Stromal lipofuscinosis of the seminal vesicle: Incidental finding in two patients treated for prostatic adenocarcinoma by prostatectomy and cryotherapy | Sangkhamanon, S. Medlicott, S.A.C. Trpkov, K. |
2018 | ||||
| 15. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. | Kittirat, Y Techasen, A Thongchot, S Loilome, W Thanan, R Yongvanit, P Sungkhamanon, S Titapun, A Khuntikeo, N Namwat, N |
2018 | ||||
| 16. | Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine | Yingpinyapat Kittirat Anchalee Techasen Suyanee Thongchot Watcharin Loilome Raynoo Thanan Puangrat Yongvanit Sakkarn Sungkhamanon Attapol Titapun Narong Khuntikeo Nisana Namwat |
2018 | ||||
| 17. | Electrocautery on sleeve gastrectomy staple line: A histological study on extracted specimens | Wittayapairoch, J. Sangkhamanon, S. Boonyagard, N. Techagumpuch, A. Udomsawaengsup, S. |
2019 | ||||
| 18. | Gleason Grading Clear and Straightforward Rules Facilitate Judgment | Trpkov, K Yilmaz, A Sangkhamanon, S Medlicott, S Donnelly, B Gotto, G Shea-Budgell, M |
2019 | ||||
| 19. | Infantile cardiac hemangioma causing right ventricular inflow obstruction | Karunasumetta, C Wongbhuddha, C Sangkhamanon, S Mokarat, B |
2019 | ||||
| 20. | Serum apurinic/apyrimidinic endodeoxyribonuclease 1 (APEX1) level as a potential biomarker of cholangiocarcinoma | Doungdean Tummanatsakun Tanakorn Proungvitaya Sittiruk Roytrakul Temduang Limpaiboon Sopit Wongkham Chaisiri Wongkham Atit Silsirivanit Ongart Somintara Sakkarn Sangkhamanon Siriporn Proungvitaya |
2019 | ||||
| 21. | Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma | Sanmai, S Proungvitaya, T Limpaiboon, T Chua-On, D Seubwai, W Roytrakul, S Wongkham, S Wongkham, C Somintara, O Sangkhamanon, S Proungvitaya, S |
2019 | ||||
| 22. | Apoptosis-Inducing Factor, Mitochondrion-Associated 3 (AIFM3) Protein Level in the Sera as a Prognostic Marker of Cholangiocarcinoma Patients | Proungvitaya, T. Techasen, A. Limpaiboon, T. Wongkham, S. Wongkham, C. Somintara, O. Patrakitkomjorn, S. |
2020 | ||||
| 23. | Incidence of and risk factors for post-parathyroidectomy hungry bone syndrome in patients with secondary hyperparathyroidism | Kritmetapak, K. Pongchaiyakul, C. |
2020 | ||||
| 24. | In vitro and in vivo anti-tumor effects of pan-her inhibitor varlitinib on cholangiocarcinoma cell lines | Hasaya Dokduang Wassana Jamnongkarn Bundit Promraksa Manida Suksawat Sureerat Padthaisong Malinee Thanee Jutarop Phetcharaburanin Nisana Namwat Sakkarn Sangkhamanon Attapol Titapun Narong Khuntikeo Poramate Klanrit Watcharin Loilome |
2020 | ||||
| 25. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma | Padthaisong, S Thanee, M Namwat, N Phetcharaburanin, J Klanrit, P Khuntikeo, N Titapun, A Sungkhamanon, S Saya, H Loilome, W |
2020 | ||||
| 26. | The length of peri-neural spreading in clinically mandibular invaded oral cavity squamous cell carcinoma | Surakunprapha, P. Winaikosol, K. |
2020 | ||||
| 27. | Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma. | Ubonrat Thamrongwaranggoon Sakkarn Sangkhamanon Wunchana Seubwai Paksiree Saranaruk U. B. O. N. CHA'ON Sopit Wongkham |
2021 | ||||
| 28. | Cancer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Autophagy-Associated Chemoresponse | Suyanee Thongchot Chiara Vidoni Alessandra Ferraresi Watcharin Loilome Narong Khuntikeo Sakkarn Sangkhamanon Attapol Titapun Ciro Isidoro Nisana Namwat |
2021 | ||||
| 29. | Cancer‐associated fibroblast‐derived il‐6 determines unfavorable prognosis in cholangiocarcinoma by affecting autophagy‐associated chemoresponse | Thongchot, S. Loilome, W. Khuntikeo, N. Titapun, A. Namwat, N. |
2021 | ||||
| 30. | CLINICAL MANIFESTATIONS AND RENAL PATHOLOGY IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE LUPUS NEPHRITIS | Sarassawan Kananuraks Rattiporn Techakajornkeart Wisansanee Karoonbooyanan Sakkarn Sangkhamanon |
2021 | ||||
| 31. | Cyclin A is upregulated by high glucose and a potential target for cholangiocarcinoma patients with diabetes mellitus | Charupong Saengboonmee Wunchana Seubwai Sakkarn Sangkhamanon Marutpong Detarya Kanlayanee Sawanyawisuth Atit Silsirivanit Sopit Wongkham |
2021 | ||||
| 32. | High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus. | Charupong Saengboonmee Marutpong Detarya Sakkarn Sangkhamanon Kanlayanee Sawanyawisuth Wunchana Seubwai Sopit Wongkham |
2021 | ||||
| 33. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction. | Kittirat, Y. Phetcharaburanin, J. Promraksa, B. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Jarearnrat, A. Thongchot, S. Mahalapbutr, P. Loilome, W. Saya, H. Namwat, N. |
2021 | ||||
| 34. | Pathum Raksa Project: Addressing Disparity in Breast Cancer Care Through National Innovation in Thailand | Koonmee, S Somintara, O Intarawichian, P Aphivatanasiri, C Sangkhamanon, S Laohawiriyakamol, S Panawattanakul, R Mahantassanapong, P Rattadilok, C Jeeravongpanich, P Krongyute, W Prachumrasee, K Alaghehbandan, R |
2021 | ||||
| 35. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles | Sitthirak, S Suksawat, M Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sangkhamanon, S Loilome, W |
2022 | ||||
| 36. | High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus | Saengboonmee, C. Sawanyawisuth, K. Seubwai, W. Wongkham, S. |
2022 | ||||
| 37. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma | Kittirat, Y Suksawat, M Thongchot, S Padthaisong, S Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Sangkhamanon, S Titapun, A Loilome, W Saya, H Namwat, N |
2022 | ||||
| 38. | Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand | Sa-Ngiamwibool, P Aphivatanasiri, C Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Wee, A Koonmee, S |
2022 | ||||
| 39. | Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand | Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Loilome, W Wee, A Koonmee, S |
2022 | ||||
| 40. | Monosodium glutamate consumption reduces the renal excretion of trimethylamine N-oxide and the abundance of Akkermansia muciniphila in the gut | Kyaw, TS Sukmak, M Nahok, K Sharma, A Silsirivanit, A Lert-Itthiporn, W Sansurin, N Senthong, V Anutrakulchai, S Sangkhamanon, S Pinlaor, S Selmi, C Hammock, BD Cha'on, U |
2022 | ||||
| 41. | Prognostic Significance of Growth Pattern in Predicting Outcome of -Associated Distal Cholangiocarcinoma in Thailand. | Kunprom, W Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Bamrungkit, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S |
2022 | ||||
| 42. | Prognostic Significance of Growth Pattern in Predicting Outcome of Opisthorchis viverrini-Associated Distal Cholangiocarcinoma in Thailand | Kunprom, W. Aphivatanasiri, C. Sa-Ngiamwibool, P. Sangkhamanon, S. Intarawichian, P. Bamrungkit, W. Thanee, M. Prajumwongs, P. Loilome, W. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Koonmee, S. |
2022 | ||||
| 43. | Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand. | Intarawichian, P Sangpaibool, S Prajumwongs, P Sa-Ngiamwibool, P Sangkhamanon, S Kunprom, W Thanee, M Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S Wee, A Aphivatanasiri, C |
2022 | ||||
| 44. | The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand. | Koonmee, S. Sangkhamanon, S. Intarawichian, P. Aphivatanasiri, C. Kunprom, W. Sa-Ngiamwibool, P. Balthaisong, S. Phuyao, C. Prajumwongs, P. Alaghehbandan, R. Thanee, M. |
2022 | ||||
| 45. | γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus. | Saengboonmee, C Sorin, S Sangkhamanon, S Chomphoo, S Indramanee, S Seubwai, W Thithuan, K Chiu, CF Okada, S Gingras, MC Wongkham, S |
2023 | ||||
| 46. | High XB130 expression in renal cell carcinoma is strongly associated with poor prognosis. | Ungarreevittaya, P. Nintra, O. Sirithanaphol, W. Chindaprasirt, J. Sangkhamanon, S. |
2023 | ||||
| 47. | Moringa oleifera leaf extract ameliorates early stages of diabetic nephropathy in streptozotocin-induced diabetic rats | Thongrung, R. Pannangpetch, P. Senggunprai, L. Sangkhamanon, S. Boonloh, K. Tangsucharit, P. |
2023 | ||||
| 48. | Pathology of Cholangiocarcinoma | Koonmee, S Sa-Ngiamwibool, P Aphivatanasiri, C Kunprom, W Intarawichian, P Bamrungkit, W Sangkhamanon, S Thanee, M |
2023 | ||||
| 49. | Programmed death-ligand 1 expression in tumor cells and tumor-infiltrating lymphocytes are associated with depth of tumor invasion in penile cancer | Sangkhamanon, S. Kotano, N. Sirithanaphol, W. Rompsaithong, U. Kiatsopit, P. Sookprasert, A. Wirasorn, K. Twinprai, P. Watcharenwong, P. Chindaprasirt, J. |
2023 | ||||
| 50. | Programmed death‑ligand 1 expression in tumor cells and tumor‑infiltrating lymphocytes are associated with depth of tumor invasion in penile cancer. | Sangkhamanon, S Kotano, N Sirithanaphol, W Rompsaithong, U Kiatsopit, P Sookprasert, A Wirasorn, K Twinprai, P Watcharenwong, P Chindaprasirt, J |
2023 | ||||
| 51. | Human papillomavirus (HPV) and Epstein-Barr virus (EBV) in Penile Cancer in Thailand | Sangkhamanon, S Thongnuapad, T Rompsaithong, U Kiatsopit, P Lumbiganon, S Twinprai, P Chindaprasirt, J Sirithanaphol, W |
2024 | ||||
| 52. | Identification of novel biomarkers to distinguish clear cell and non-clear cell renal cell carcinoma using bioinformatics and machine learning. | Panwoon, C Seubwai, W Thanee, M Sangkhamanon, S |
2024 | ||||
| 53. | Evaluation of Thai Traditional Wound Healing Preparation Activity in Rats: Influence of Sesamol Levels and Preparation Methods. | Panngam, W Leucha, P Somchai, Sangkhamanon, S Tiyaworanant, S |
2025 | ||||
| 54. | Influence of processing conditions on sesame lignan content and wound healing activity of Thai traditional ointment formulations | Panngam, W. Leucha, P. Suriyakrai, S. Sangkhamanon, S. Tiyaworanant, S. |
2025 | Count | 33 | 35 | 26 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Xanthohumol inhibits STAT3 activation pathway leaDing to growth suppression and apoptosis induction in human cholangiocarcinoma cells | Dokduang, H. Yongvanit, P. Namwat, N. Pairojkul, C. Loilome, W. |
2016 |
Oncology Reports 4 (35), pp. 2065-2072 |
||||||||
| 2. | Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment | Yothaisong, S. Dokduang, H. Namwat, N. Yongvanit, P. Loilome, W. |
2017 |
Tumor Biology 3 (39), pp. |
||||||||
| 3. | Nimotuzumab inhibits cholangiocarcinoma cell metastasis via suppression of the epithelial-mesenchymal transition process | Thanee, M. Techasen, A. Namwat, N. Yongvanit, P. Loilome, W. |
2017 |
Anticancer Research 7 (37), pp. 3591-3597 |
||||||||
| 4. | Programmed death-ligand 1 (PD-L1) expression associated with a high neutrophil/lymphocyte ratio in cholangiocarcinoma | Sookprasert, A. Wirasorn, K. Titapun, A. Pugkhem, A. |
2017 |
Asian Pacific Journal of Cancer Prevention 6 (18), pp. 1671-1674 |
||||||||
| 5. | Targeting hexokinase II as a possible therapy for cholangiocarcinoma | Seubwai, W. Phoomak, C. Cha'on, U. Boonmars, T. |
2017 |
Biochemical and Biophysical Research Communications 2 (484), pp. 409-415 |
||||||||
| 6. | Inhibitory effect of nvp-bkm120 on cholangiocarcinoma cell growth | Dokduang, H. Yothaisong, S. Techasen, A. Yongvanit, P. Khuntikeo, N. Titapun, A. Loilome, |
2018 |
Oncology Letters 2 (16), pp. 1627-1633 |
||||||||
| 7. | Stromal lipofuscinosis of the seminal vesicle: Incidental finding in two patients treated for prostatic adenocarcinoma by prostatectomy and cryotherapy | Sangkhamanon, S. Medlicott, S.A.C. Trpkov, K. |
2018 |
Human Pathology: Case Reports (11), pp. 21-24 |
||||||||
| 8. | Electrocautery on sleeve gastrectomy staple line: A histological study on extracted specimens | Wittayapairoch, J. Sangkhamanon, S. Boonyagard, N. Techagumpuch, A. Udomsawaengsup, S. |
2019 |
Journal of the Medical Association of Thailand 2 (102), pp. 203-206 |
||||||||
| 9. | Infantile cardiac hemangioma causing right ventricular inflow obstruction | Karunasumetta, C. | 2019 |
Asian Cardiovascular and Thoracic Annals 7 (27), pp. 597-599 |
||||||||
| 10. | Serum apurinic/apyrimidinic endodeoxyribonuclease 1 (APEX1) level as a potential biomarker of cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Wongkham, S. Wongkham, C. Silsirivanit, A. Somintara, O. Patrakitkomjorn, S. |
2019 |
Biomolecules 9 (9), pp. |
||||||||
| 11. | Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma | Proungvitaya, T. Limpaiboon, T. Seubwai, W. Wongkham, S. Wongkham, C. Somintara, O. Patrakitkomjorn, S. |
2019 |
Oncology Letters 6 (17), pp. 5275-5282 |
||||||||
| 12. | Apoptosis-inducing factor, mitochondrion-associated 3 (Aifm3) protein level in the sera as a prognostic marker of cholangiocarcinoma patients | Proungvitaya, T. Techasen, A. Limpaiboon, T. Wongkham, S. Wongkham, C. Somintara, O. Patrakitkomjorn, S. |
2020 |
Biomolecules 7 (10), pp. 1-12 |
||||||||
| 13. | Incidence of and risk factors for post-parathyroidectomy hungry bone syndrome in patients with secondary hyperparathyroidism | Kritmetapak, K. Pongchaiyakul, C. |
2020 |
Renal Failure 1 (42), pp. 1118-1126 |
||||||||
| 14. | In vitro and in vivo anti-tumor effects of pan-her inhibitor varlitinib on cholangiocarcinoma cell lines | Dokduang, H. Promraksa, B. Thanee, M. Phetcharaburanin, J. Namwat, N. Titapun, A. Khuntikeo, N. Klanrit, P. Loilome, W. |
2020 |
Drug Design, Development and Therapy (14), pp. 2319-2334 |
||||||||
| 15. | The length of peri-neural spreading in clinically mandibular invaded oral cavity squamous cell carcinoma | Surakunprapha, P. Winaikosol, K. |
2020 |
Journal of the Medical Association of Thailand 5 (103), pp. 459-464 |
||||||||
| 16. | Aberrant GLUT1 expression is associated with carcinogenesis and progression of liver fluke-associated cholangiocarcinoma | Seubwai, W. Cha'on, U. Wongkham, S. |
2021 |
In Vivo 1 (35), pp. 267-274 |
||||||||
| 17. | Cancer‐associated fibroblast‐derived il‐6 determines unfavorable prognosis in cholangiocarcinoma by affecting autophagy‐associated chemoresponse | Thongchot, S. Loilome, W. Khuntikeo, N. Titapun, A. Namwat, N. |
2021 |
Cancers 9 (13), pp. |
||||||||
| 18. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction | Kittirat, Y. Phetcharaburanin, J. Promraksa, B. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Jarearnrat, A. Thongchot, S. Mahalapbutr, P. Loilome, W. Saya, H. Namwat, N. |
2021 |
Frontiers in Public Health (9), pp. |
||||||||
| 19. | Pathum raksa project: Addressing disparity in breast cancer care through national innovation in Thailand | Koonmee, S. Somintara, O. Intarawichian, P. Prachumrasee, K. |
2021 |
Cancer Management and Research (13), pp. 8737-8753 |
||||||||
| 20. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles | Suksawat, M. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Jarearnrat, A. Sangkhamanon, S. Loilome, W. |
2022 |
PeerJ (10), pp. |
||||||||
| 21. | High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus | Saengboonmee, C. Sawanyawisuth, K. Seubwai, W. Wongkham, S. |
2022 |
Nutrition and Cancer 5 (74), pp. 1734-1744 |
||||||||
| 22. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma | Kittirat, Y. Suksawat, M. Thongchot, S. Padthaisong, S. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Titapun, A. Loilome, W. Saya, H. Namwat, N. |
2022 |
Frontiers in Pharmacology (13), pp. |
||||||||
| 23. | Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand | Sa-Ngiamwibool, P. Aphivatanasiri, C. Sangkhamanon, S. Intarawichian, P. Kunprom, W. Thanee, M. Prajumwongs, P. Loilome, W. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Wee, A. Koonmee, S. |
2022 |
HPB 11 (24), pp. 1944-1956 |
||||||||
| 24. | Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand | Aphivatanasiri, C. Sa-ngiamwibool, P. Sangkhamanon, S. Intarawichian, P. Kunprom, W. Thanee, M. Prajumwongs, P. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Loilome, W. Wee, A. Koonmee, S. |
2022 |
Frontiers in Medicine (9), pp. |
||||||||
| 25. | Monosodium glutamate consumption reduces the renal excretion of trimethylamine N-oxide and the abundance of Akkermansia muciniphila in the gut | Nahok, K. Sharma, A. Silsirivanit, A. Lert-Itthiporn, W. Sansurin, N. Senthong, V. Anutrakulchai, S. Sangkhamanon, S. Pinlaor, S. Cha’on, U. |
2022 |
Biochemical and Biophysical Research Communications (630), pp. 158-166 |
||||||||
| 26. | Prognostic Significance of Growth Pattern in Predicting Outcome of Opisthorchis viverrini-Associated Distal Cholangiocarcinoma in Thailand | Kunprom, W. Aphivatanasiri, C. Sa-Ngiamwibool, P. Sangkhamanon, S. Intarawichian, P. Bamrungkit, W. Thanee, M. Prajumwongs, P. Loilome, W. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Koonmee, S. |
2022 |
Frontiers in Public Health (10), pp. |
||||||||
| 27. | The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand | Koonmee, S. Sangkhamanon, S. Intarawichian, P. Aphivatanasiri, C. Kunprom, W. Sa-Ngiamwibool, P. Balthaisong, S. Phuyao, C. Prajumwongs, P. Alaghehbandan, R. Thanee, M. |
2022 |
Frontiers in Public Health (10), pp. |
||||||||
| 28. | High XB130 expression in renal cell carcinoma is strongly associated with poor prognosis | Ungarreevittaya, P. Nintra, O. Sirithanaphol, W. Chindaprasirt, J. Sangkhamanon, S. |
2023 |
Annals of Diagnostic Pathology (67), pp. |
||||||||
| 29. | Moringa oleifera leaf extract ameliorates early stages of diabetic nephropathy in streptozotocin-induced diabetic rats | Thongrung, R. Pannangpetch, P. Senggunprai, L. Sangkhamanon, S. Boonloh, K. Tangsucharit, P. |
2023 |
Journal of Applied Pharmaceutical Science 8 (13), pp. 158-166 |
||||||||
| 30. | Pathology of Cholangiocarcinoma | Koonmee, S. Sa-ngiamwibool, P. Aphivatanasiri, C. Kunprom, W. Intarawichian, P. Bamrungkit, W. Sangkhamanon, S. Thanee, M. |
2023 |
Recent Results in Cancer Research (219), pp. 91-107 |
||||||||
| 31. | Programmed death-ligand 1 expression in tumor cells and tumor-infiltrating lymphocytes are associated with depth of tumor invasion in penile cancer | Sangkhamanon, S. Kotano, N. Sirithanaphol, W. Rompsaithong, U. Kiatsopit, P. Sookprasert, A. Wirasorn, K. Twinprai, P. Watcharenwong, P. Chindaprasirt, J. |
2023 |
Biomedical Reports 1 (19), pp. |
||||||||
| 32. | Human papillomavirus (HPV) and Epstein-Barr virus (EBV) in Penile Cancer in Thailand | Sangkhamanon, S. Thongnuapad, T. Rompsaithong, U. Kiatsopit, P. Lumbiganon, S. Twinprai, P. Chindaprasirt, J. Sirithanaphol, W. |
2024 |
Asian Pacific Journal of Cancer Prevention 10 (25), pp. 3543-3549 |
||||||||
| 33. | Influence of processing conditions on sesame lignan content and wound healing activity of Thai traditional ointment formulations | Panngam, W. Leucha, P. Suriyakrai, S. Sangkhamanon, S. Tiyaworanant, S. |
2025 |
Journal of Ethnopharmacology (349), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells. | Dokduang, H Yongvanit, P Namwat, N Pairojkul, C Sangkhamanon, S Yageta, MS Murakami, Y Loilome, W |
2016 |
Oncology reports 4 (35), pp. 2065-72 |
|
| 2. | High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma. | Chua-On, D Proungvitaya, T Techasen, A Limpaiboon, T Roytrakul, S Wongkham, S Wongkham, C Somintara, O Sungkhamanon, S Proungvitaya, S |
2016 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 10 (37), pp. 13659-13667 |
|
| 3. | Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment. | Yothaisong, S Dokduang, H Anzai, N Hayashi, K Namwat, N Yongvanit, P Sangkhamanon, S Jutabha, P Endou, H Loilome, W |
2017 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 3 (39), pp. 1010428317694545 |
|
| 4. | Targeting hexokinase II as a possible therapy for cholangiocarcinoma. | Thamrongwaranggoon, U Seubwai, W Phoomak, C Sangkhamanon, S Cha'on, U Boonmars, T Wongkham, S |
2017 |
Biochemical and biophysical research communications 2 (484), pp. 409-415 |
|
| 5. | Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process. | Padthaisong, S Thanee, M Techasen, A Namwat, N Yongvanit, P Liwatthakun, A Hankla, K Sangkhamanon, S Loilome, W |
2017 |
Anticancer research 7 (37), pp. 3591-3597 |
|
| 6. | Programmed Death-Ligand 1 (PD-L1) Expression Associated with a High Neutrophil/Lymphocyte Ratio in Cholangiocarcinoma | Sangkhamanon, S Jongpairat, P Sookprasert, A Wirasorn, K Titapun, A Pugkhem, A Ungareevittaya, P Chindaprasirt, J |
2017 |
Asian Pacific journal of cancer prevention : APJCP 6 (18), pp. 1671-1674 |
|
| 7. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. | Kittirat, Y Techasen, A Thongchot, S Loilome, W Thanan, R Yongvanit, P Sungkhamanon, S Titapun, A Khuntikeo, N Namwat, N |
2018 |
Oncology letters 1 (15), pp. 347-353 |
|
| 8. | Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth. | Padthaisong, S Dokduang, H Yothaisong, S Techasen, A Namwat, N Yongvanit, P Khuntikeo, N Titapun, A Sangkhamanon, S Loilome, W |
2018 |
Oncology letters 2 (16), pp. 1627-1633 |
|
| 9. | Concordance of "Case Level" Global, Highest, and Largest Volume Cancer Grade Group on Needle Biopsy Versus Grade Group on Radical Prostatectomy. | Trpkov, K Sangkhamanon, S Yilmaz, A Medlicott, SAC Donnelly, B Gotto, G Shea-Budgell, M |
2018 |
The American journal of surgical pathology 11 (42), pp. 1522-1529 |
|
| 10. | Bladder Malakoplakia in Systemic Sclerosis Patient: A Case Report and Review Literature. | Sirithanaphol, W Sangkhamanon, S Netwijitpan, S Foocharoen, C |
2018 |
Journal of endourology case reports 1 (4), pp. 91-93 |
|
| 11. | Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma. | Sanmai, S Proungvitaya, T Limpaiboon, T Chua-On, D Seubwai, W Roytrakul, S Wongkham, S Wongkham, C Somintara, O Sangkhamanon, S Proungvitaya, S |
2019 |
Oncology letters 6 (17), pp. 5275-5282 |
|
| 12. | Gleason Grading: Clear and Straightforward Rules Facilitate Judgment. | Trpkov, K Yilmaz, A Sangkhamanon, S Medlicott, S Donnelly, B Gotto, G Shea-Budgell, M |
2019 |
The American journal of surgical pathology 2 (43), pp. 291-292 |
|
| 13. | Infantile cardiac hemangioma causing right ventricular inflow obstruction. | Karunasumetta, C Wongbhuddha, C Sangkhamanon, S Mokarat, B |
2019 |
Asian cardiovascular & thoracic annals (), pp. 218492319836899 |
|
| 14. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma. | Padthaisong, S Thanee, M Namwat, N Phetcharaburanin, J Klanrit, P Khuntikeo, N Titapun, A Sungkhamanon, S Saya, H Loilome, W |
2020 |
Journal of translational medicine 1 (18), pp. 64 |
|
| 15. | Incidence of and risk factors for post-parathyroidectomy hungry bone syndrome in patients with secondary hyperparathyroidism. | Kritmetapak, K Kongpetch, S Chotmongkol, W Raruenrom, Y Sangkhamanon, S Pongchaiyakul, C |
2020 |
Renal failure 1 (42), pp. 1118-1126 |
|
| 16. | In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines. | Dokduang, H Jamnongkarn, W Promraksa, B Suksawat, M Padthaisong, S Thanee, M Phetcharaburanin, J Namwat, N Sangkhamanon, S Titapun, A Khuntikeo, N Klanrit, P Loilome, W |
2020 |
Drug design, development and therapy (14), pp. 2319-2334 |
|
| 17. | Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma. | Thamrongwaranggoon, U Sangkhamanon, S Seubwai, W Saranaruk, P Cha'on, U Wongkham, S |
2021 |
In vivo (Athens, Greece) 1 (35), pp. 267-274 |
|
| 18. | Pathum Raksa Project: Addressing Disparity in Breast Cancer Care Through National Innovation in Thailand. | Koonmee, S Somintara, O Intarawichian, P Aphivatanasiri, C Sangkhamanon, S Laohawiriyakamol, S Panawattanakul, R Mahantassanapong, P Rattadilok, C Jeeravongpanich, P Krongyute, W Prachumrasee, K Alaghehbandan, R |
2021 |
Cancer management and research (13), pp. 8737-8753 |
|
| 19. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction. | Kittirat, Y Phetcharaburanin, J Promraksa, B Kulthawatsiri, T Wangwiwatsin, A Klanrit, P Sangkhamanon, S Jarearnrat, A Thongchot, S Mahalapbutr, P Loilome, W Saya, H Namwat, N |
2021 |
Frontiers in public health (9), pp. 766455 |
|
| 20. | High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus. | Saengboonmee, C Detarya, M Sangkhamanon, S Sawanyawisuth, K Seubwai, W Wongkham, S |
2021 |
Nutrition and cancer (), pp. 1-11 |
|
| 21. | Monosodium glutamate consumption reduces the renal excretion of trimethylamine N-oxide and the abundance of Akkermansia muciniphila in the gut. | Kyaw, TS Sukmak, M Nahok, K Sharma, A Silsirivanit, A Lert-Itthiporn, W Sansurin, N Senthong, V Anutrakulchai, S Sangkhamanon, S Pinlaor, S Selmi, C Hammock, BD Cha'on, U |
2022 |
Biochemical and biophysical research communications (630), pp. 158-166 |
|
| 22. | Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand. | Intarawichian, P Sangpaibool, S Prajumwongs, P Sa-Ngiamwibool, P Sangkhamanon, S Kunprom, W Thanee, M Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S Wee, A Aphivatanasiri, C |
2022 |
Frontiers in oncology (12), pp. 1004220 |
|
| 23. | Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand. | Sa-Ngiamwibool, P Aphivatanasiri, C Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Wee, A Koonmee, S |
2022 |
HPB : the official journal of the International Hepato Pancreato Biliary Association 11 (24), pp. 1944-1956 |
|
| 24. | Prognostic Significance of Growth Pattern in Predicting Outcome of -Associated Distal Cholangiocarcinoma in Thailand. | Kunprom, W Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Bamrungkit, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S |
2022 |
Frontiers in public health (10), pp. 816028 |
|
| 25. | The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand. | Koonmee, S Sangkhamanon, S Intarawichian, P Aphivatanasiri, C Kunprom, W Sa-Ngiamwibool, P Balthaisong, S Phuyao, C Prajumwongs, P Alaghehbandan, R Thanee, M |
2022 |
Frontiers in public health (10), pp. 792847 |
|
| 26. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles. | Sitthirak, S Suksawat, M Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sangkhamanon, S Loilome, W |
2022 |
PeerJ (10), pp. e13876 |
|
| 27. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma. | Kittirat, Y Suksawat, M Thongchot, S Padthaisong, S Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Sangkhamanon, S Titapun, A Loilome, W Saya, H Namwat, N |
2022 |
Frontiers in pharmacology (13), pp. 897368 |
|
| 28. | Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand. | Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Loilome, W Wee, A Koonmee, S |
2022 |
Frontiers in medicine (9), pp. 893252 |
|
| 29. | High XB130 expression in renal cell carcinoma is strongly associated with poor prognosis. | Ungarreevittaya, P Nintra, O Sirithanaphol, W Chindaprasirt, J Sangkhamanon, S |
2023 |
Annals of diagnostic pathology (67), pp. 152190 |
|
| 30. | Programmed death‑ligand 1 expression in tumor cells and tumor‑infiltrating lymphocytes are associated with depth of tumor invasion in penile cancer. | Sangkhamanon, S Kotano, N Sirithanaphol, W Rompsaithong, U Kiatsopit, P Sookprasert, A Wirasorn, K Twinprai, P Watcharenwong, P Chindaprasirt, J |
2023 |
Biomedical reports 1 (19), pp. 44 |
|
| 31. | γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus. | Saengboonmee, C Sorin, S Sangkhamanon, S Chomphoo, S Indramanee, S Seubwai, W Thithuan, K Chiu, CF Okada, S Gingras, MC Wongkham, S |
2023 |
World journal of gastroenterology 28 (29), pp. 4416-4432 |
|
| 32. | Pathology of Cholangiocarcinoma. | Koonmee, S Sa-Ngiamwibool, P Aphivatanasiri, C Kunprom, W Intarawichian, P Bamrungkit, W Sangkhamanon, S Thanee, M |
2023 |
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer (219), pp. 91-107 |
|
| 33. | Human papillomavirus (HPV) and Epstein-Barr virus (EBV) in Penile Cancer in Thailand. | Sangkhamanon, S Thongnuapad, T Rompsaithong, U Kiatsopit, P Lumbiganon, S Twinprai, P Chindaprasirt, J Sirithanaphol, W |
2024 |
Asian Pacific journal of cancer prevention : APJCP 10 (25), pp. 3543-3549 |
|
| 34. | Identification of novel biomarkers to distinguish clear cell and non-clear cell renal cell carcinoma using bioinformatics and machine learning. | Panwoon, C Seubwai, W Thanee, M Sangkhamanon, S |
2024 |
PloS one 6 (19), pp. e0305252 |
|
| 35. | Evaluation of Thai Traditional Wound Healing Preparation Activity in Rats: Influence of Sesamol Levels and Preparation Methods. | Panngam, W Leucha, P Somchai, Sangkhamanon, S Tiyaworanant, S |
2025 |
Journal of ethnopharmacology (), pp. 119909 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma | Daraporn Chua-on Tanakorn Proungvitaya Anchalee Techasen Temduang Limpaiboon Sittiruk Roytrakul Sopit Wongkham Chaisiri Wongkham Ongart Somintara Sakkarn Sungkhamanon Siriporn Proungvitaya |
2016 |
TUMOR BIOLOGY 10.0 (37.0), pp. 13659.0-13667.0 |
18 | 0 | 0 | 0 | 0 | 0 | 18 | |
| 2. | Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells | Hasaya Dokduang Puangrat Yongvanit Nisana Namwat Chawalit Pairojkul Sakkarn Sangkhamanon Mika Sakurai Yageta Yoshinori Murakami Watcharin Loilome |
2016 |
ONCOLOGY REPORTS 4.0 (35.0), pp. 2065.0-2072.0 |
24 | 0 | 0 | 0 | 0 | 0 | 24 | |
| 3. | Inhibition of L-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment | Supak Yothaisong Hasaya Dokduang Naohiko Anzai Keitaro Hayashi Nisana Namwat Puangrat Yongvanit Sakkarn Sangkhamanon Promsuk Jutabha Hitoshi Endou Watcharin Loilome |
2017 |
TUMOR BIOLOGY 3.0 (39.0), pp. |
47 | 0 | 0 | 0 | 0 | 0 | 47 | |
| 4. | MR imaging findings of a patient with isolated intrahepatic splenosis mistaken for hepatocellular carcinoma | Kulyada Somsap Nittaya Chamadol Attapol Titapun Chawalit Pairojkul Sakkarn Sangkhamanon |
2017 |
BJR CASE REPORTS 1.0 (3.0), pp. |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 5. | Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process | Sureerat Padthaisong Malinee Thanee Anchalee Techasen Nisana Namwat Puangrat Yongvanit Aekkaphod Liwatthakun Khittisak Hankla Sakkarn Sangkhamanon Watcharin Loilome |
2017 |
ANTICANCER RESEARCH 7.0 (37.0), pp. 3591.0-3597.0 |
29 | 0 | 0 | 0 | 0 | 0 | 29 | |
| 6. | Targeting hexokinase II as a possible therapy for cholangiocarcinoma | Ubonrat Thamrongwaranggoon Wunchana Seubwai Chatchai Phoomak Sakkarn Sangkhamanon Ubon Cha'on Thidarat Boonmars Sopit Wongkham |
2017 |
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2.0 (484.0), pp. 409.0-415.0 |
32 | 0 | 0 | 0 | 0 | 0 | 32 | |
| 7. | Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis | Nattaporn Phanthaphol Anchalee Techasen Watcharin Loilome Suyanee Thongchot Raynoo Thanan Sakkarn Sungkhamanon Narong Khuntikeo Puangrat Yongvanit Nisana Namwat |
2017 |
ONCOLOGY LETTERS 5.0 (14.0), pp. 5973.0-5979.0 |
15 | 0 | 0 | 0 | 0 | 0 | 15 | |
| 8. | Biopsy Global Grade Group vs. Highest Grade Group vs. Largest Volume Cancer Grade Group: Concordance of Biopsy 'Case Level' and Radical Prostatectomy Grade Groups | Kiril Trpkov Sakkarn Sangkhamanon Asli Yilmaz Shaun Medlicott Panche Zdravkovski Tarek Bismar Melissa A. Shea-Budgell |
2018 |
LABORATORY INVESTIGATION (98.0), pp. 394.0-394.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 9. | Concordance of Case Level Global, Highest, and Largest Volume Cancer Grade Group on Needle Biopsy Versus Grade Group on Radical Prostatectomy | Kiril Trpkov Sakkarn Sangkhamanon Asli Yilmaz Shaun A. C. Medlicott Bryan Donnelly Geoffrey Gotto Melissa Shea-Budgell |
2018 |
AMERICAN JOURNAL OF SURGICAL PATHOLOGY 11.0 (42.0), pp. 1522.0-1529.0 |
25 | 0 | 0 | 0 | 0 | 0 | 25 | |
| 10. | Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth | Sureerat Padthaisong Hasaya Dokduang Supak Yothaisong Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapol Titapun Sakkarn Sangkhamanon Watcharin Loilome |
2018 |
ONCOLOGY LETTERS 2.0 (16.0), pp. 1627.0-1633.0 |
14 | 0 | 0 | 0 | 0 | 0 | 14 | |
| 11. | Pan-class I PI3K inhibitor inhibits cholangiocarcinoma cell growth | Sureerat Padthaisong Hasaya Dokduang Supak Yothaisong Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapon Titapun Sakkarn Sangkhamanon Watcharin Loilome |
2018 |
CANCER SCIENCE (109.0), pp. 745.0-745.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 12. | Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine | Yingpinyapat Kittirat Anchalee Techasen Suyanee Thongchot Watcharin Loilome Raynoo Thanan Puangrat Yongvanit Sakkarn Sungkhamanon Attapol Titapun Narong Khuntikeo Nisana Namwat |
2018 |
ONCOLOGY LETTERS 1.0 (15.0), pp. 347.0-353.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 13. | Gleason Grading Clear and Straightforward Rules Facilitate Judgment | Kiril Trpkov Asli Yilmaz Sakkarn Sangkhamanon Shaun Medlicott Bryan Donnelly Geoffrey Gotto Melissa Shea-Budgell |
2019 |
AMERICAN JOURNAL OF SURGICAL PATHOLOGY 2.0 (43.0), pp. 291.0-292.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 14. | Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma | Doungdean Tummanatsakun Tanakorn Proungvitaya Sittiruk Roytrakul Temduang Limpaiboon Sopit Wongkham Chaisiri Wongkham Atit Silsirivanit Ongart Somintara Sakkarn Sangkhamanon Siriporn Proungvitaya |
2019 |
BIOMOLECULES 9.0 (9.0), pp. |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
| 15. | Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma | Surangkana Sanmai Tanakorn Proungvitaya Temduang Limpaiboon Daraporn Chua-On Wunchana Seubwai Sittiruk Roytrakul Sopit Wongkham Chaisiri Wongkham Ongart Somintara Sakkarn Sangkhamanon Siriporn Proungvitaya |
2019 |
ONCOLOGY LETTERS 6.0 (17.0), pp. 5275.0-5282.0 |
11 | 0 | 0 | 0 | 0 | 0 | 11 | |
| 16. | Apoptosis-Inducing Factor, Mitochondrion-Associated 3 (AIFM3) Protein Level in the Sera as a Prognostic Marker of Cholangiocarcinoma Patients | Daraporn Chua-on Tanakorn Proungvitaya Doungdean Tummanatsakun Anchalee Techasen Temduang Limpaiboon Sittiruk Roytrakul Sopit Wongkham Chaisiri Wongkham Ongart Somintara Sakkarn Sangkhamanon Siriporn Proungvitaya |
2020 |
BIOMOLECULES 7.0 (10.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 17. | Incidence of and risk factors for post-parathyroidectomy hungry bone syndrome in patients with secondary hyperparathyroidism | Kittrawee Kritmetapak Sawinee Kongpetch Wijittra Chotmongkol Yutapong Raruenrom Sakkarn Sangkhamanon Chatlert Pongchaiyakul |
2020 |
RENAL FAILURE 1.0 (42.0), pp. 1118.0-1126.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 18. | In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines | Hasaya Dokduang Wassana Jamnongkarn Bundit Promraksa Manida Suksawat Sureerat Padthaisong Malinee Thanee Jutarop Phetcharaburanin Nisana Namwat Sakkarn Sangkhamanon Attapol Titapun Narong Khuntikeo Poramate Klanrit Watcharin Loilome |
2020 |
DRUG DESIGN DEVELOPMENT AND THERAPY (14.0), pp. 2319.0-2334.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 19. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma | Sureerat Padthaisong Malinee Thanee Nisana Namwat Jutarop Phetcharaburanin Poramate Klanrit Narong Khuntikeo Attapol Titapun Sakkarn Sungkhamanon Hideyuki Saya Watcharin Loilome |
2020 |
JOURNAL OF TRANSLATIONAL MEDICINE 1.0 (18.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 20. | Aberrant GLUT1 Expression Is Associated With Carcinogenesis and Progression of Liver Fluke-associated Cholangiocarcinoma | Ubonrat Thamrongwaranggoon Sakkarn Sangkhamanon Wunchana Seubwai Paksiree Saranaruk U. B. O. N. CHA'ON Sopit Wongkham |
2021 |
IN VIVO 1.0 (35.0), pp. 267.0-274.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 21. | Cancer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Autophagy-Associated Chemoresponse | Suyanee Thongchot Chiara Vidoni Alessandra Ferraresi Watcharin Loilome Narong Khuntikeo Sakkarn Sangkhamanon Attapol Titapun Ciro Isidoro Nisana Namwat |
2021 |
CANCERS 9.0 (13.0), pp. |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 22. | CLINICAL MANIFESTATIONS AND RENAL PATHOLOGY IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE LUPUS NEPHRITIS | Sarassawan Kananuraks Rattiporn Techakajornkeart Wisansanee Karoonbooyanan Sakkarn Sangkhamanon |
2021 |
NEPHROLOGY (26.0), pp. 50.0-50.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 23. | Cyclin A is upregulated by high glucose and a potential target for cholangiocarcinoma patients with diabetes mellitus | Charupong Saengboonmee Wunchana Seubwai Sakkarn Sangkhamanon Marutpong Detarya Kanlayanee Sawanyawisuth Atit Silsirivanit Sopit Wongkham |
2021 |
CANCER SCIENCE (112.0), pp. 540.0-540.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 24. | High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus | Charupong Saengboonmee Marutpong Detarya Sakkarn Sangkhamanon Kanlayanee Sawanyawisuth Wunchana Seubwai Sopit Wongkham |
2021 |
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 25. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction | Yingpinyapat Kittirat Jutarop Phetcharaburanin Bundit Promraksa Thanaporn Kulthawatsiri Arporn Wangwiwatsin Poramate Klanrit Sakkarn Sangkhamanon Apiwat Jarearnrat Suyanee Thongchot Panupong Mahalapbutr Watcharin Loilome Hideyuki Saya Nisana Namwat |
2021 |
FRONTIERS IN PUBLIC HEALTH (9.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 26. | Pathum Raksa Project: Addressing Disparity in Breast Cancer Care Through National Innovation in Thailand | Supinda Koonmee Ongart Somintara Piyapharom Intarawichian Chaiwat Aphivatanasiri Sakkarn Sangkhamanon Suphawat Laohawiriyakamol Rujira Panawattanakul Phanchanut Mahantassanapong Chayanoot Rattadilok Piyarat Jeeravongpanich Wilart Krongyute Krisada Prachumrasee Reza Alaghehbandan |
2021 |
CANCER MANAGEMENT AND RESEARCH (13.0), pp. 8737.0-8753.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title |
|---|
| ชื่อโครงการ | Authors | ประเภทโครงการ | ปีงบประมาณ | ทุนวิจับ |
|---|